Pfizer tops S&P 500 leaderboard after reaffirming 2024 revenue and profit
2024/25 guidance reaffirmed$1 billion impact from Inflation Reduction ActExpected to meet 3.25 leverage target by end of 2025Embattled pharmaceutical firm Pfizer (PFE:NYSE) topped the S&P 500 index leaderboard on Tuesday (17 Dec),...
18 December 2024
